Ensysce Biosciences to participate in UBS, Piper Sandler healthcare conferences
ENSC•Ensysce Biosciences will participate in two investor conferences through management of recently acquired Cy Biopharma, with events scheduled for November 17 in London and December 3 in New York.
1. Conference schedule
Ensysce Biosciences management of recently acquired Cy Biopharma will take part in a UBS Healthcare Therapeutics Conference fireside chat in London on November 17, 2026, from 2:40 to 3:10 p.m. GMT. The company will also present at the 38th Annual Piper Sandler Healthcare Conference in New York on December 3, 2026, from 2:10 to 2:30 p.m. ET.




